Merck KGaA (MKKGY)
36.31
-0.30
(-0.82%)
USD |
OTCM |
May 17, 16:00
Merck Enterprise Value: 87.13B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 87.13B |
| May 16, 2024 | 87.78B |
| May 15, 2024 | 86.67B |
| May 14, 2024 | 82.70B |
| May 13, 2024 | 80.63B |
| May 10, 2024 | 80.93B |
| May 09, 2024 | 81.17B |
| May 08, 2024 | 80.07B |
| May 07, 2024 | 79.93B |
| May 06, 2024 | 79.33B |
| May 03, 2024 | 79.36B |
| May 02, 2024 | 78.50B |
| May 01, 2024 | 76.96B |
| April 30, 2024 | 77.28B |
| April 29, 2024 | 78.13B |
| April 26, 2024 | 78.30B |
| April 25, 2024 | 77.91B |
| April 24, 2024 | 78.72B |
| April 23, 2024 | 79.72B |
| April 22, 2024 | 76.43B |
| April 19, 2024 | 75.78B |
| April 18, 2024 | 75.74B |
| April 17, 2024 | 76.20B |
| April 16, 2024 | 77.76B |
| April 15, 2024 | 77.80B |
| Date | Value |
|---|---|
| April 12, 2024 | 78.83B |
| April 11, 2024 | 79.13B |
| April 10, 2024 | 78.30B |
| April 09, 2024 | 80.54B |
| April 08, 2024 | 79.93B |
| April 05, 2024 | 79.54B |
| April 04, 2024 | 80.65B |
| April 03, 2024 | 82.17B |
| April 02, 2024 | 82.04B |
| April 01, 2024 | 84.28B |
| March 28, 2024 | 84.78B |
| March 27, 2024 | 83.70B |
| March 26, 2024 | 82.87B |
| March 25, 2024 | 83.48B |
| March 22, 2024 | 84.22B |
| March 21, 2024 | 84.20B |
| March 20, 2024 | 82.70B |
| March 19, 2024 | 82.26B |
| March 18, 2024 | 81.95B |
| March 15, 2024 | 82.41B |
| March 14, 2024 | 83.72B |
| March 13, 2024 | 84.04B |
| March 12, 2024 | 84.83B |
| March 11, 2024 | 82.67B |
| March 08, 2024 | 82.70B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
49.97B
Minimum
May 31 2019
124.02B
Maximum
Dec 29 2021
82.56B
Average
84.25B
Median
Apr 20 2023
Enterprise Value Benchmarks
| Affimed NV | 12.80M |
| InflaRx NV | 5.359M |
| MorphoSys AG | 2.801B |
| BioNTech SE | 5.173B |
| Immatics NV | 520.46M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 631.07M |
| Revenue (Quarterly) | 5.627B |
| Total Expenses (Quarterly) | 5.035B |
| EPS Diluted (Quarterly) | 0.2886 |
| Gross Profit Margin (Quarterly) | 55.46% |
| Profit Margin (Quarterly) | 11.22% |
| Earnings Yield | 3.87% |
| Operating Earnings Yield | 4.91% |
| Normalized Earnings Yield | 3.847 |